利用ActionADE实现信息连续性以减少有害药物再暴露:随机对照试验研究方案
本研究在加拿大不列颠哥伦比亚省开展两项平行分组、三盲随机对照试验,纳入因处方门诊药物发生不良药物事件的成人。ActionADE记录事件并通过算法分配患者,实验组将信息传至PharmaNet供社区药房查看,对照组仅存本地记录。主试验纳入3600名药物不良反应患者,评估12个月内致害药物再配药;次要试验评估用药依从性。
要点
- ActionADE可快速记录不良药物事件并跨医疗部门传递标准化信息。
- 主试验评估信息连续性对12个月内致害药物再配药的影响。
- 次要试验评估信息连续性对12个月内用药依从性的影响。
核心结论
- 通过ActionADE实现不良药物事件信息连续性,有望减少致害药物再暴露,并为卫生信息技术整合提供政策依据。
研究设计与样本
- 在加拿大不列颠哥伦比亚省参与医院开展两项平行分组、三盲随机对照试验。
- 纳入因处方门诊药物发生不良药物事件的成人,主试验纳入3600名药物不良反应患者。
- ActionADE用算法判定资格并分配至实验组或对照组。
主要发现
- 原文未报告研究结果,仅描述研究方案与主要结局指标。
- 主试验主要结局为12个月内致害药物或同类药物再配药。
- 次要试验主要结局为致害药物用药依从性,次要结局包括卫生服务利用和死亡率。
关键数值与推荐
- 实验组ActionADE将信息传至PharmaNet,社区药房尝试再配药时显示不良药物事件信息。
- 对照组ActionADE将信息保留在本地记录中。
- 主试验纳入3600名药物不良反应成人,随访12个月。
临床怎么用
- 临床医生可通过ActionADE记录不良药物事件,促进跨系统信息共享。
- 社区药房在再配药时可查看PharmaNet中的不良药物事件信息,辅助用药安全决策。
局限性
- 本文为研究方案,尚未报告实施效果与结局数据。
- 研究在加拿大不列颠哥伦比亚省开展,外推性需结合当地卫生信息系统背景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Repeat exposures to culprit medications are a common cause of preventable adverse drug events. Health information technologies have the potential to reduce repeat adverse drug events by improving information continuity. However, they rarely interoperate to ensure providers can view adverse drug events documented in other systems. We designed ActionADE to enable rapid documentation of adverse drug events and communication of standardized information across health sectors by integrating with legacy systems. We will leverage ActionADE's implementation to conduct two parallel, randomized trials: patients with adverse drug reactions in the main trial and those diagnosed with non-adherence in a secondary trial. Primary objective of the main trial is to evaluate the effects of providing information continuity about adverse drug reactions on culprit medication re-dispensations over 12 months. Primary objective of the secondary trial is to evaluate the effect of providing information continuity on adherence over 12 months. METHODS: We will conduct two parallel group, triple-blind randomized controlled trials in participating hospitals in British Columbia, Canada. We will enroll adults presenting to hospital with an adverse drug event to prescribed outpatient medication. Clinicians will document the adverse drug event in ActionADE. The software will use an algorithm to determine patient eligibility and allocate eligible patients to experimental or control. In the experimental arm, ActionADE will transmit information to PharmaNet, where adverse drug event information will be displayed in community pharmacies when re-dispensations are attempted. In the control arm, ActionADE will retain information in the local record. We will enroll 3600 adults with an adverse drug reaction into the main trial. The main trial's primary outcome is re-dispensation of a culprit or same-class medication within 12 months; the secondary trial's primary outcome will be adherence to culprit medication. Secondary outcomes include health services utilization and mortality. DISCUSSION: These studies have the potential to guide policy decisions and investments needed to drive health information technology integrations to prevent repeat adverse drug events. We present an example of how a health information technology implementation can be leveraged to conduct pragmatic randomized controlled trials. TRIAL REGISTRATION: ClinicalTrials.gov NCT04568668 , NCT04574648 . Registered on 1 October 2020.
引用
- Hau JP, Brasher PMA, Cragg A, et al. Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial. Trials. 2021. PMID: 33546752. doi:10.1186/s13063-021-05061-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。